Stereotaxis, Inc. · AMEX:STXS
Dr. Nathan Fischel reported a 15.30% stake in Stereotaxis, Inc. (Schedule 13D/A)
Event Nov 9, 2026 · Filed Nov 12, 2026
Dr. Nathan Fischel reported a 15.30% stake in Stereotaxis, Inc., 15,628,395 shares, with active intent on Nov 9, 2026. Filed Nov 12, 2026 (Schedule 13D/A).
- Stake
- 15.30%
- Shares
- 15,628,395
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| DAFNA Capital Management, LLC | 15.10% | 15,333,446 |
| Dr. Nathan Fischel | 15.30% | 15,628,395 |
| Dr. Fariba Ghodsian | 15.10% | 15,333,446 |
| DAFNA LifeScience, L.P. | 7.90% | 8,005,938 |
| DAFNA LifeScience Select, L.P. | 7.30% | 7,327,508 |
Source
Download original · View original at SEC